Tenenbaum M J, Archer G L
South Med J. 1980 Feb;73(2):140-3, 149. doi: 10.1097/00007611-198002000-00006.
Teichoic acid antibodies were measured in serum using counter immunoelectrophoresis and immunodiffusion technics with a partially purified antigen. Immunodiffusion titers of greather than or equal to 1:4 were obtained in 15/16 patients with S aureus endocarditis but in only two of 122 noninfected individuals and in no patients with endocarditis caused by other gram-positive bacteria. These same elevated titers of antibody were noted in seven of 23 patients with nonendocarditis S aureus infections. These seven patients all had either prolonged, untreated staphylococcal bacteremia or a primary site of infection which was not promptly eradicated. Six of these seven patients responded to four weeks or less of antimicrobial therapy without developing any complications. The development of high titers of teichoic acid antibodies during the course of S aureus bacteremia could not be reliably used to determine the appropriate duration of antistaphylococcal treatment.
使用对流免疫电泳和免疫扩散技术,以部分纯化的抗原检测血清中的磷壁酸抗体。16例金黄色葡萄球菌性心内膜炎患者中有15例免疫扩散效价大于或等于1:4,而122例未感染个体中只有2例出现此情况,其他革兰氏阳性菌引起的心内膜炎患者则无此现象。23例非心内膜炎金黄色葡萄球菌感染患者中有7例也出现了相同的抗体效价升高情况。这7例患者均有长期未治疗的葡萄球菌血症或未及时根除的原发性感染部位。这7例患者中有6例对抗菌治疗4周或更短时间有反应,且未出现任何并发症。在金黄色葡萄球菌血症病程中出现高滴度磷壁酸抗体并不能可靠地用于确定抗葡萄球菌治疗的合适疗程。